Background
Usher syndrome (USH), an autosomal recessive disorder, is a clinically and genetically heterogeneous disease. USH is characterized by retinitis pigmentosa (RP), bilateral sensorineural hearing impairment and intact vestibular responses [
1]. It is the most prevailing cause of the human hereditary deafness and blindness. In worldwide, the general prevalence of USH approximately ranges from 3.3 to 6.4 per 100,000 individuals [
2]. Up to now, it is unavailability of a therapy for the USH.
Clinically, according to the severity and progression of vision and hearing loss of patients, USH classified into USH type I (USH1), USH type II (USH2), and USH type III (USH3) [
3]. Besides, approximately 20–30% cases are categorized as atypical USH. USH1 is the most serious form in the three types, patients with USH1 have congenital profound hearing loss and begin to lose their vision early in life. Different from the USH1 patients defined as having congenital deafness and blindness within the first decade of life, patients with USH2 exhibit congenital mild-moderate hearing and vision loss in the second decade of life, and generally show normal vestibular function in all their lives. USH2 is the most common form of USH and USH2 patients account for more than 50% of all USH patients [
2,
4]. USH3 patients are not born deaf and blind. They usually show a gradual loss of their hearing and vision.
Up to now, 16 genes have been identified that may cause USH (
https://sph.uth.edu/retnet/sum-dis.htm), three genes of them (
USH2A (usherin) [
5],
ADGRV1 (Adhesion G Protein-Coupled Receptor V1) [
6] and
DFNB31 (autosomal recessive deafness 31) [
7]) are the USH2 genes.
USH2A gene is the major pathogenic gene for USH2 and responsible for more than 74% USH2 cases [
8].
USH2A gene is located on chromosome 1q41 and has two alternatively spliced isoforms. The shorter
USH2A isoform was first identified in 1998 [
5] and the much longer
USH2A isoform b was identified by van Wijk et al. in 2004 [
9]. To date, all 72 exons of
USH2A isoform b have been carried out plenty of mutational analyses and found many pathogenic mutations (including splicing mutations at splice sites) [
10,
11]. The protein usherin, encoded by the isoform b of
USH2A, is presumed with 5202 amino acids and anchored on the cell membrane [
12]. In mammalian photoreceptors, the usherin are expressed specifically in the connecting cilia and involved in the cargo delivery from the inner segment to the outer segment [
13]. Previous research has been shown that mutations of
USH2A could cause nonsyndromic recessive RP [
14,
15]. What is more,
USH2A gene also related to tactile sensitivity and acuity [
16].
In this study, five deleterious variants and 14 non-pathogenic variants in the USH2A gene were identified in four Chinese USH2 patients by mutation screening. Two of the pathogenic variants we detected were novel.
Discussion
Currently, 16 genes associated with USH have been identified, and three are USH2-causing gene. The
USH2A gene causes 30–40% of USH2 cases and 10–15% of recessive RP cases [
19]. Usherin is localized to a spatially restricted membrane microdomain in mammalian photoreceptors [
13]. Previous researches have shown that congenital usherin protein mutations can induce the connecting cilium disorder and eventually lead to blindness [
20].
Up to now, mutation screening in Chinese patients was revealed 25 mutations in previous researches [
15,
18,
21‐
24]. In Southern population of China, 8.47% of sporadic RP patients are belong to USH [
21]. In this study, we identified two novel variants (a missense variant and a nonsense variant) in the
USH2A gene of four Chinese patients diagnosed with USH2 and found three reported mutations.
Isoform b of
USH2A consists 8 domains, including N-terminal signal peptide (SP), laminin G-like domain (Lam GL), laminin N-terminal (Lam NT), laminin-type EGF-like domain (EGF Lam), fibronectin Type III (FN3), laminin G domain (LamG), transmembrane region (TM), and a PDZ-binding motif (PBM) at its C-terminal end [
9]. By the PBM interacted with the PDZ domain of harmonin and whirlin, USH2A integrated into the USH protein network [
25].
All of the two novel pathogenic variants are located in the FN3 domain (Fig.
4a). c.4217C > A (p.Ser1406X) is located in the fourth FN3 domain, and c.11780A > G (p.Asp3927Gly) is located in the 24th FN3 domain. In addition, reported mutation c.8232G > C (p.Trp2744Cys) is located in the fourteenth FN3 domain.
Heterozygous nonsense variant c.4217C > A (p.Ser1406X) causing a premature stop codon at 1406 is located on exon 19, and leads to a subsequent loss of 3796 amino acids, which make the protein usherin to lose more than 70% of its amino acids including 30 TM domains, 2 LamG domains, TM domain, and PBM domain. Therefore, heterozygous nonsense variant c.4217C > A (p.Ser1406X) affecting the structure and function of the protein usherin have a great possibility of causing the USH2. Novel missense variant p.Asp3927Gly (c.11780A > G) replaces a polaraspartic acid with a nonpolar hydrophobic glycine at codon 3927. Amino acid substitutions caused by reported missense variant p.Trp2744Cys (c.8232G > C) occur at highly conserved sites among the tested species. Interestingly, sites of novel missense variant p.Asp3927Gly (c.11780A > G) in the Human, Troglodyte, Mulatta, Chicken, Zebrafish and Bovine are conserved while the Mouse not.
For the Family # 2 and Family # 3, the following possibilities could be attributed to the unknown allelic variants: 1. Variants in deep-intronic regions of USH2A were not detected because this part of the genome was not covered in the screening. 2. Variants in regulatory elements except the USH2A gene cannot be excluded. 3. The duplication or deletion of other alleles may not be detected due to the absence of copy number variation analysis.
Because of unknown allelic variants in Family # 2 and Family # 3, we suppose that other pathogenic variants may exist in patients. Data from Family # 2 was supportive for the pathogenicity of the novel nonsense variant c.4217C > A (p.Ser1406X) and novel missense variant c.11780A > G (p.Asp3927Gly). The other three pathogenic variants are known pathogenic mutations that have been reported. However, sufficient biological and clinical evidence was required to reveal the relationship between the identified variants and the USH2. The detailed reasons of these pathogenic mutations leading to visual defects and hearing impairment have not been elucidated, and pending further function and mechanism investigations.
In all the three USH2-causing genes,
USH2A gene is the most important causative gene, and the usherin which encoded by
USH2A is crucial for the long-term maintenance of mammalian photoreceptors [
13]. Accordingly, identification of the mutations in the
USH2A gene will not only elucidate the role of
USH2A in USH2, but also aid the clinical diagnosis and help to find effective treatments for USH2.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.